Product ID |
CAS Number |
Product Name |
Quantity |
AS-0387 |
7152-15-0 |
Ethyl isobutyrylacetate |
|
AS-1252 |
119356-77-3 |
Dapoxetine hydrochloride |
|
AS-1461 |
2629-72-3 |
4-Pyridinepropanol |
|
AS-1469 |
22282-99-1 |
4-Bromo-2-methylpyridine |
|
AS-2276 |
40473-01-6 |
2-Bromo-5-chloropyridine |
|
AS-2374 |
15964-79-1 |
METHYL HOMOVERATRATE |
|
AS-3443 |
16222-42-7 |
2-(TRIFLUOROMETHYL)ANISOLE |
|
AS-3813 |
114772-53-1 |
4'-Methyl-2-cyanobiphenyl |
|
AS-4399 |
127667-01-0 |
2-FLUORO-5-METHOXYBENZONITRILE |
|
AS-4861 |
206860-48-2 |
4-Fluoro-2-(trifluoromethyl)benzyl bromide |
|
AS-5017 |
17302-46-4 |
METHYL 5-NITROSALICYLATE |
|
AS-5168 |
3208-16-0 |
2-Ethylfuran |
|
AS-5251 |
6833-47-2 |
trans-4-Ethylcyclohexanecarboxylic acid |
|
AS-5353 |
372118-67-7 |
2-AMINOMETHYLPYRIMIDINE HYDROCHLORIDE |
|
AS-5358 |
1199-77-5 |
alpha-Methylcinnamic acid |
|
AS-5847 |
34941-91-8 |
2-Chloro-4-fluoropyridine |
|
AS-6089 |
34810-13-4 |
9-Anthraldehyde oxime |
|
AS-6871 |
68797-61-5 |
5-Bromo-4,6-dichloropyrimidine |
|
AS-7343 |
22889-78-7 |
4-Amino-3,5-dichloropyridine |
|
AS-7544 |
68076-36-8 |
tert-Butyl N-(4-aminobutyl)carbamate |
|
AS-7617 |
8/7/5815 |
BREDERECK'S REAGENT |
|
AS-7900 |
1137826-05-1 |
6-hydroxyquinoline-3-carboxylic acid |
|
AS-7907 |
885519-21-1 |
6-BROMO-4-METHOXY-1H-INDAZOLE |
|
AS-8153 |
68957-50-6 |
5-bromo-6-methyl-3-nitropyridin-2-amine |
|
AS-8961 |
106719-44-2 |
BOC-D-LYS-OH |
|
JR02-H072 |
1365639-13-9 |
2-Azaspiro[3.3]heptane hemioxalate |
|
JR6-L3651 |
1352814-10-8 |
4,7,10,13,16,19-Hexaoxa-22-azaheptacosanoic acid, 27-[(3aS,4S,6aR)-hexahydro-2-oxo-1H-thieno[3,4-d]imidazol-4-yl]-23-oxo- |
|
JR6-L4293 |
127705-27-5 |
Hexadecanoic acid, 16-(methylthio)-, methyl ester |
|
JR6-L4456 |
101469-92-5 |
1-Pyrrolidinecarboxylic acid, 3-hydroxy-, 1,1-dimethylethyl ester, (3S)- |
|
JR6-L5536 |
153403-52-2 |
Benzoxazole, 2-chloro-7-fluoro- |
|
JR6-L6961 |
1187928-03-5 |
Benzenemethanamine, a,4-bis(trifluoromethyl)-, (aR)- |
|
JR6-L8023 |
154777-21-6 |
Pyrrolidine, 2-(4-methoxyphenyl)-, (2R)- |
|
|
|
|
|
|
|
|
|
|
|
|
|